-+ 0.00%
-+ 0.00%
-+ 0.00%

MetaVia Reports Phase 1b Clinical Trial Results Of DA-1726

Benzinga·01/05/2026 13:32:56
語音播報

Statistically Significant (p=0.006) Waist Circumference Reduction of 9.8 cm at Day 54

Significant Direct Hepatic Activity with a 23.7% Reduction in Liver Stiffness (VCTE) by Day 54

Strong Glycemic Response with a 12.3 mg/dL Fasted Glucose Reduction by Day 54

Robust Weight Loss with 9.1% Reduction (21.2 lbs) by Day 54